bioAffinity shifts its focus on CyPath Lung as the second-quarter 2025 loss widens, with rising adoption and new market expansion underway.

INTZ posts fifth straight quarter of revenue growth in Q2 2025, fueled by DoD contracts and rising adoption of its Shield cybersecurity suite.

INTZ posts fifth straight quarter of revenue growth in Q2 2025, fueled by DoD contracts and rising adoption of its Shield cybersecurity suite.

VASO reports a second-quarter 2025 loss as lower imaging deliveries and rising costs pressured revenue and profit margins.

VASO reports a second-quarter 2025 loss as lower imaging deliveries and rising costs pressured revenue and profit margins.

NRXS reports strong second-quarter 2025 revenue growth and lower losses, but gross margin compression remains a key concern.

CVV reports weaker second-quarter 2025 results as revenue and earnings decline, while new system launch signals long-term growth focus.

SELF delivers higher second-quarter 2025 earnings as rising occupancy and tenant satisfaction lifted core performance.

SELF delivers higher second-quarter 2025 earnings as rising occupancy and tenant satisfaction lifted core performance.

Nexxen heads into second-quarter results with strong CTV momentum and rising industry adoption, eyeing triple-digit profit growth.